Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Clinical trial NCT03574220 · WITHDRAWN
Trial details
- NCT number
- NCT03574220
- Sponsor
- Case Comprehensive Cancer Center
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2020-03-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.